mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
1e-05 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
2e-05 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
3e-05 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
3e-05 |
mRNA |
GW843682X |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
4e-05 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
4e-05 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
6e-05 |
mRNA |
PF-3758309 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
7e-05 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0001 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0001 |